Ali Alhasan is CEO and founder of the company NanoPalm. He holds a Ph.D. in nanomedicine, with expertise in nano-drug delivery and gene therapy and five years of experience in executive management.
In his role as CEO, Alhasan formulates the strategic and business plans for accelerating therapy translation globally and trains talents in deep tech, nanotech, and gene editing tech.
Alhasan co-developed deep tech to leverage large language models for biotech discovery. He also co-invented Nanopalm’s biorobots for the delivery of gene editing primers and helped discover four nanomedicines for four different genetic diseases.
He is also an associate professor at King Abdulaziz City for Science and Technology and an adjunct professor at Alfaisal University, establishing collaboration agreements between the two.
As associate professor, he is the principal researcher for development and innovation in nanomedicine and the fourth industrial revolution.
In his role as adjunct professor, Alhasan teaches nanomedicine and mentors postgraduate and undergraduate students. He also co-established the Cancer Nanoscience Program.
Previously, Alhasan served in executive leadership roles at KACST as deputy at the Joint Centers of Excellence Program (2021), deputy of the Life Science and Environment Research Institute (2020), director of the Center of Excellence for Biomedicine (2020), and director of Strategic Initiatives (2016).
Alhasan was a post-doctoral scholar at the University of California in 2015 and received his Ph.D. in the Interdepartmental Biological Sciences Program from Northwestern University in 2013.
In 2008, he received a master’s degree in biotechnology also from Northwestern University, while in 2001, he received his bachelor’s degree in medical technology from King Abdulaziz University.
Alhasan was granted the Leader of the Year award from the Ministry of Communication and Information Technology in 2024. In 2018, he received the Outstanding Investigator Award from KACST.
He was granted the Outstanding Researcher Award from the International Institute for Nanotechnology in 2012.
